News
Oxford-SII and Moderna Ebola Vaccines to Join DRC Trial
The two Ebola vaccine candidates are ChAdOx1, developed by the University of Oxford with the Serum Institute of India, and Moderna’s mRNA-1469.
imphoenix82
- November 6, 2026
- 0 Comments
- 57 Views
-
